Search results for "133"

showing 10 items of 144 documents

Hemopoietic and angiogenetic progenitors in healthy athletes: different responses to endurance and maximal exercise

2010

J Appl Physiol. 2010 Jul;109(1):60-7. Epub 2010 May 6. Hemopoietic and angiogenetic progenitors in healthy athletes: different responses to endurance and maximal exercise. Bonsignore MR, Morici G, Riccioni R, Huertas A, Petrucci E, Veca M, Mariani G, Bonanno A, Chimenti L, Gioia M, Palange P, Testa U. SourceBiomedical Department, Internal and Specialistic Medicine (DIBIMIS), Section of Pneumology, University of Palermo, Via Trabucco, 180, 90146 Palermo, Italy. marisa@ibim.cnr.it Abstract The effects of endurance or maximal exercise on mobilization of bone marrow-derived hemopoietic and angiogenetic progenitors in healthy subjects are poorly defined. In 10 healthy amateur runners, we collect…

AdultMalemedicine.medical_specialtyPhysiologyNeovascularization PhysiologicAntigens CD34Physical exerciseHematopoietic Cell Growth FactorsSettore BIO/09 - FisiologiaRunningangiopoietin; marathon; circulating progenitors; growth factorsAntigens CDEndurance trainingPhysiology (medical)Internal medicinegrowth factorsmedicineHumansAC133 AntigenProgenitor cellGlycoproteinsErythroid Precursor CellsbiologyAthletesbusiness.industryangiopoietinHealthy subjectsEndothelial Cellscirculating progenitorMiddle AgedCadherinsHematopoietic Stem Cellsbiology.organism_classificationHaematopoiesisEndocrinologyAthletesPhysical EnduranceCytokinesAngiogenesis Inducing Agentsadult; angiogenesis inducing agents; angiopoietin; antigens; athletes; blood; cadherins; cd; cd34; circulating progenitors; cytokines; endothelial cells; erythroid precursor cells; glycoproteins; granulocytes; growth factors; hematopoietic cell growth factors; hematopoietic stem cells; humans; male; marathon; middle aged; neovascularization; peptides; physical endurance; physiologic; physiology; runningAC133 antigenMaximal exercisemarathonPeptidesbusinessGranulocytesJournal of Applied Physiology
researchProduct

"Table 37" of "Energy dependence of event shapes and of alpha(s) at LEP-2."

1999

Distributions of the Total Jet Broadening (BSUM) at cm energies 133, 161 and 172 GeV.

Astrophysics::High Energy Astrophysical PhenomenaE+ E- --> HADRONSE+ E- --> JETSE+ E- ScatteringExclusiveHigh Energy Physics::ExperimentDN/DBSUMSingle Differential DistributionJet ProductionNuclear Experiment133.0-172.0
researchProduct

"Table 23" of "Energy dependence of event shapes and of alpha(s) at LEP-2."

1999

Distributions of Planarity at cm energies 133, 161 and 172 GeV.

Astrophysics::High Energy Astrophysical PhenomenaE+ E- --> HADRONSE+ E- --> JETSE+ E- ScatteringExclusiveHigh Energy Physics::ExperimentSingle Differential DistributionJet ProductionComputer Science::Computational GeometryNuclear ExperimentDN/DPLANARITY133.0-172.0
researchProduct

"Table 21" of "Energy dependence of event shapes and of alpha(s) at LEP-2."

1999

Distributions of Sphericity at cm energies 133, 161 and 172 GeV.

Astrophysics::High Energy Astrophysical PhenomenaE+ E- --> HADRONSE+ E- --> JETSE+ E- ScatteringExclusiveHigh Energy Physics::ExperimentSingle Differential DistributionJet ProductionNuclear Experiment133.0-172.0DN/DSPHERICITY
researchProduct

Cannabinoid CB1 receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.

2007

The purpose of the present study was to examine whether cannabinoid receptor agonists influence spontaneous contractile activity of longitudinal muscle in mouse ileum in vitro. Isolated segments of mouse ileum displayed spontaneous contractions with an amplitude and frequency of about 300 mg and 30 cpm, respectively. The endocannabinoid anandamide (1-100 microM), the selective cannabinoid CB(1) receptor agonist, ACEA (0.1 microM-10 microM), but not the selective cannabinoid CB(2) receptor agonist, JWH 133 (0.1 microM-10 microM), reduced in a concentration-dependent manner the spontaneous mechanical activity. The inhibitory effect consisted in a decrease of the mean amplitude of longitudinal…

AtropineMaleAgonistmedicine.medical_specialtyCB1 receptorIndolesCannabinoid receptorPolyunsaturated Alkamidesmedicine.drug_classmedicine.medical_treatmentMouse ileumArachidonic AcidsTetrodotoxinIn Vitro TechniquesDepolarization-induced suppression of inhibitionHexamethoniumReceptor Cannabinoid CB2Micechemistry.chemical_compoundPiperidinesReceptor Cannabinoid CB1IleumInternal medicineCannabinoid Receptor ModulatorsmedicineAnimalsCannabinoidPharmacologyDose-Response Relationship DrugCannabinoidsChemistryMuscle SmoothCannabinoid Receptor AgonistsReceptor antagonistEndocannabinoid systemAcetylcholineMice Inbred C57BLNG-Nitroarginine Methyl EsterEndocrinologyApaminJWH-133PyrazolesCannabinoidRimonabantSpontaneous mechanical activityEndocannabinoidsMuscle Contraction
researchProduct

"Table 1" of "Measurement of event shape and inclusive distributions at s**(1/2) = 130-GeV and 136-GeV."

1997

mean values for event shape variables.

BSUME+ E- --> HADRONSE+ E- ScatteringExclusiveBMAXJET-MASSTHRUST91.2-133.0
researchProduct

Efectos del desarrollo sostenible percibido por el consumidor. Una propuesta de modelo de hipermercados en Ecuador

2020

Resumen El objetivo de este trabajo fue analizar la incidencia del desarrollo sostenible sobre la cadena de efectos: valor percibido - capital de marca - lealtad. Para ello, se propone un modelo teórico de relaciones que se contrasta a partir de una muestra de 317 clientes de hiper mercados en Ecuador. Los resultados, aplicando una metodología exploratoria y confirmatoria, combinada con regresión por mínimos cuadrados parciales, mostraron que tanto las acciones de desarrollo sostenible como el valor percibido son pilares maestros sobre los que se puede apoyar la estrategia minorista. Ambas se muestran como variables clave por su naturaleza, en cuanto son multidimensio nales, y por su alcanc…

Business managementKnowledge management//vocabularies.unesco.org/thesaurus/concept7775 [http]Strategy and ManagementConsumidoresEmpresasManagement of Technology and InnovationBusinessInnovación tecnológica//id.loc.gov/authorities/subjects/sh92005743 [http]desarrollo sostenibleperceived valueMarketingQ16 Agricultural technologysustainable developmentBusiness enterprisesAgriculturavalor percebidoAgroindustria//id.loc.gov/authorities/subjects/sh85031491 [http]AgricultureInnovaciones tecnológicasCapitalpercepção do consumidorcapital de marcaO33 Technological changedesenvolvimento sustentável//id.loc.gov/authorities/subjects/sh94002204 [http]Economics and Econometricslealdade//vocabularies.unesco.org/thesaurus/concept10614 [http]lcsh:BusinessAgroindustry//vocabularies.unesco.org/thesaurus/concept598 [http]Business and International Managementlealtadpercepción del consumidor//vocabularies.unesco.org/thesaurus/concept4616 [http]//id.loc.gov/authorities/subjects/sh85133143 [http]O35 Social InnovationAdministración de empresas//vocabularies.unesco.org/thesaurus/concept1749 [http]consumer perceptionEmpresas familiaresbrand equityEstrategia de desarrolloloyaltyvalor percibido//vocabularies.unesco.org/thesaurus/concept1351 [http]//id.loc.gov/authorities/subjects/sh85018285 [http]Gestión del conocimientoMarcas de empresasConsumersTechnological innovationsHouse brandslcsh:HF5001-6182//id.loc.gov/authorities/subjects/sh85002415 [http]Finance//id.loc.gov/authorities/subjects/sh97007353 [http]Estudios Gerenciales
researchProduct

CD133 expression in placenta chorioangioma presenting as a giant asymptomatic mass

2021

Background: Placental chorioangioma is the most common benign non-trophoblastic neoplasm of the placenta. Its clinical relevance lies in the size of the tumor since larger masses cause pregnancy complications, including an unfavorable neonatal outcome. Case presentation: We report the case of a 34-year-old second gravida and nullipara at the 35th week of gestation, admitted to the gynecological department for antibiotic-resistant fever. The cardiotocography performed during hospitalization showed an abnormal fetal pattern. A 2250 g newborn was delivered by cesarean section. No complications were observed during childbirth and postpartum was insignificant. On gross inspection a white fleshy …

CD31Adultmedicine.medical_specialtyMedicine (General)Placenta Diseasesgiant asymptomatic maPlacentaCase Reportgiant asymptomatic massR5-920PregnancyPlacentamedicineChildbirthCD133 expression; Giant asymptomatic mass; Placental chorioangioma; Adult; Cesarean Section; Endothelial Cells; Female; Humans; Infant Newborn; Placenta; Pregnancy; Hemangioma; Placenta Diseases; Pregnancy Complications NeoplasticHumansClinical significanceCardiotocographyGiant asymptomatic massPregnancyFetusNeoplasticplacental chorioangiomamedicine.diagnostic_testObstetricsbusiness.industryCesarean SectionCD133 expression; Giant asymptomatic mass; Placental chorioangiomaEndothelial CellsInfantGeneral Medicinemedicine.diseaseNewbornPregnancy Complicationsmedicine.anatomical_structurePlacental chorioangiomaembryonic structuresGestationFemaleGiant asymptomatic mabusinessHemangiomaCD133 expression
researchProduct

The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation.

2010

Abstract Colon cancer stem cells (CSC) can be identified with AC133, an antibody that detects an epitope on CD133. However, recent evidence suggests that expression of CD133 is not restricted to CSCs, but is also expressed on differentiated tumor cells. Intriguingly, we observed that detection of the AC133 epitope on the cell surface decreased upon differentiation of CSC in a manner that correlated with loss of clonogenicity. However, this event did not coincide with a change in CD133 promoter activity, mRNA, splice variant, protein expression, or even cell surface expression of CD133. In contrast, we noted that with CSC differentiation, a change occured in CD133 glycosylation. Thus, AC133 …

Cancer ResearchGlycosylationGlycosylationCellular differentiationCellAC 133 EpitopeDown-RegulationMice SCIDEpitopechemistry.chemical_compoundEpitopesMiceCancer stem cellAntigens CDMice Inbred NODProminin-1medicineTumor Cells CulturedAnimalsHumansProtein IsoformsAC133 AntigenRNA MessengerPromoter Regions GeneticneoplasmsGlycoproteinsbiologyCell DifferentiationMolecular biologycarbohydrates (lipids)Gene Expression Regulation Neoplasticmedicine.anatomical_structureOncologychemistryembryonic structuresColonic Neoplasmsbiology.proteinNeoplastic Stem CellsAntibodyStem cellPeptidesCancer research
researchProduct

Colon Cancer Stem Cells: Bench-to-Bedside—New Therapeutical Approaches in Clinical Oncology for Disease Breakdown

2011

It is widely accepted by the scientific community that cancer, including colon cancer, is a “stem cell disease”. Until a few years ago, common opinion was that all neoplastic cells within a tumor contained tumorigenic growth capacity, but recent evidences hint to the possibility that such a feature is confined to a small subset of cancer-initiating cells, also called cancer stem cells (CSCs). Thus, malignant tumors are organized in a hierarchical fashion in which CSCs give rise to more differentiated tumor cells. CSCs possess high levels of ATP-binding cassette (ABC) transporters and anti-apoptotic molecules, active DNA-repair, slow replication capacities and they produce growth factors tha…

Cancer Researchcancer stem cellColorectal cancerCellPopulationDiseaseReviewBioinformaticslcsh:RC254-282colorectal cancer (CRC)Cancer stem cellMedicineCD133educationeducation.field_of_studycancer stem cell; colorectal cancer (CRC); CD133; differentiationbusiness.industryCancerdifferentiationlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasemedicine.anatomical_structureOncologyCancer cellCancer researchStem cellbusiness
researchProduct